MedPath

Carbon monoxide

Generic Name
Carbon monoxide
Drug Type
Small Molecule
Chemical Formula
CO
CAS Number
630-08-0
Unique Ingredient Identifier
7U1EE4V452
Background

Carbon monoxide (CO) is a colorless, odorless, and tasteless gas that has a slightly lower density than air. It is toxic to hemoglobin utilizing animals (including humans), when encountered in concentrations above about 35 ppm, although it is also formed in normal animal metabolism in low quantities, and is thought to have some normal biological/homeostatic functions . Carbon monoxide (CO), is a ubiquitous environmental product of organic combustion, which is also formed endogenously in the human body, as the byproduct of heme metabolism . Exhaled CO (eCO), similar to exhaled nitric oxide (eNO), has been evaluated as a candidate breath biomarker of pathophysiological states, including smoking status, and inflammatory diseases of the lung and other organs. Exhalation of corbon monoxide values have been studied as potential indicators of inflammation in asthma, stable COPD and exacerbations, cystic fibrosis, lung cancer, and during surgery or critical care .

A test of the diffusing capacity of the lungs for carbon monoxide (DLCO), is one of the most clinically valuable tests of lung function testing. The technique was first described 100 years ago, and applied to clinical practice many years after. The DLCO measures the ability of the lungs to transfer gas from inhaled air to the red blood cells in pulmonary capillaries. The DLCO test is both convenient and simple for the patient to undergo. The ten seconds of breath-holding required for the DLCO maneuver is easier for most patients to perform than the forced exhalation required for other respiratory tests .

Carbon monoxide is presently used in small amounts in low oxygen modified atmosphere packaging systems (MAP) for fresh meat to stabilize and maintain natural meat color. This use of CO has been generally recognized as safe (GRAS) in several packaging applications for fresh meat products. Since 2002, FDA has favorably reviewed three GRAS notifications for carbon monoxide use in fresh meat packaging . The FDA classifies this drug as permitted as a food additive in the packaging and preparation of food products, while following the federal code of regulations .

There have been several concerns voiced of over the use of carbon monoxide in food products , , . The European Union has banned the use of carbon monoxide as a color stabilizer in meat and fish. A December 2001 report from the European Commission's Scientific Committee on Food concluded that the gas did not pose a risk provided that food was maintained adequately cold during storage and transport to prevent the growth of microorganisms . In New Zealand, the use of carbon monoxide in fish preparation has been banned, as it may mask the effects of food spoilage and bacterial growth .

Indication

Used as a marker of respiratory status in spirometry tests , .

Food additive for pigment fixation in meat .

Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia

Early Phase 1
Recruiting
Conditions
Oligospermia
Infertility Unexplained
Interventions
First Posted Date
2024-04-02
Last Posted Date
2024-04-02
Lead Sponsor
Ain Shams University
Target Recruit Count
120
Registration Number
NCT06342856
Locations
🇪🇬

Ain Shams University, Cairo, Egypt

Effects of Carbon Monoxide Breathing on Blood Vessel Function

Phase 1
Completed
Conditions
Endothelial Dysfunction
Interventions
First Posted Date
2017-03-01
Last Posted Date
2019-04-01
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
9
Registration Number
NCT03067701
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension

Phase 1
Withdrawn
Conditions
Hypertension, Pulmonary
Interventions
First Posted Date
2012-02-01
Last Posted Date
2017-06-09
Lead Sponsor
University of Illinois at Chicago
Registration Number
NCT01523548
Locations
🇺🇸

University of Illinois at Chicago Medical Center, Chicago, Illinois, United States

Efficacy and Safety Assessment of an Anti-Cold Preparation in the Symptomatic Treatment of Common Cold and Flu-Like Syndrome

Phase 3
Conditions
Common Cold
Flu-like Syndrome
Interventions
Drug: Resfenol
Drug: Placebo
First Posted Date
2009-07-16
Last Posted Date
2009-07-16
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
146
Registration Number
NCT00940836
Locations
🇧🇷

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

Phase 2
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
First Posted Date
2005-07-22
Last Posted Date
2006-09-12
Lead Sponsor
Groningen Research Institute for Asthma and COPD
Target Recruit Count
20
Registration Number
NCT00122694
Locations
🇳🇱

University Medical Center Groningen, Department of Pulmonary Diseases, Groningen, Netherlands

Carbon Monoxide to Prevent Lung Inflammation

Phase 1
Completed
Conditions
Respiratory Distress Syndrome, Adult
First Posted Date
2004-10-18
Last Posted Date
2019-12-17
Lead Sponsor
National Institutes of Health Clinical Center (CC)
Target Recruit Count
35
Registration Number
NCT00094406
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath